These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Liu Y; Jiang P; Capkova K; Xue D; Ye L; Sinha SC; Mackman N; Janda KD; Liu C Cancer Res; 2011 Oct; 71(20):6492-502. PubMed ID: 21880589 [TBL] [Abstract][Full Text] [Related]
5. Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. Corrales L; Ajona D; Rafail S; Lasarte JJ; Riezu-Boj JI; Lambris JD; Rouzaut A; Pajares MJ; Montuenga LM; Pio R J Immunol; 2012 Nov; 189(9):4674-83. PubMed ID: 23028051 [TBL] [Abstract][Full Text] [Related]
6. Increased human tumor necrosis factor-α levels induce procoagulant change in porcine endothelial cells in vitro. Lee KG; Lee H; Ha JM; Lee YK; Kang HJ; Park CG; Kim SJ Xenotransplantation; 2012; 19(3):186-95. PubMed ID: 22702470 [TBL] [Abstract][Full Text] [Related]
7. Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression. Kocatürk B; Tieken C; Vreeken D; Ünlü B; Engels CC; de Kruijf EM; Kuppen PJ; Reitsma PH; Bogdanov VY; Versteeg HH J Thromb Haemost; 2015 Sep; 13(9):1683-93. PubMed ID: 26179105 [TBL] [Abstract][Full Text] [Related]
9. Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation? Davila M; Robles-Carrillo L; Unruh D; Huo Q; Gardiner C; Sargent IL; Adam M; Woodhams BJ; Francis JL; Bogdanov VY; Amirkhosravi A J Thromb Haemost; 2014 Feb; 12(2):186-96. PubMed ID: 24298933 [TBL] [Abstract][Full Text] [Related]
10. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Shoji M; Hancock WW; Abe K; Micko C; Casper KA; Baine RM; Wilcox JN; Danave I; Dillehay DL; Matthews E; Contrino J; Morrissey JH; Gordon S; Edgington TS; Kudryk B; Kreutzer DL; Rickles FR Am J Pathol; 1998 Feb; 152(2):399-411. PubMed ID: 9466566 [TBL] [Abstract][Full Text] [Related]
11. Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria meningitidis-exposed whole blood. Øvstebø R; Hellum M; Aass HC; Trøseid AM; Brandtzaeg P; Mollnes TE; Henriksson CE Innate Immun; 2014 Jul; 20(5):552-60. PubMed ID: 24051102 [TBL] [Abstract][Full Text] [Related]
12. C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis. Liu J; Tan Y; Zhang J; Zou L; Deng G; Xu X; Wang F; Ma Z; Zhang J; Zhao T; Liu Y; Li Y; Zhu B; Guo B J Hepatol; 2015 Feb; 62(2):354-62. PubMed ID: 25200905 [TBL] [Abstract][Full Text] [Related]
13. Cancer cells release anaphylatoxin C5a from C5 by serine protease to enhance invasiveness. Nitta H; Murakami Y; Wada Y; Eto M; Baba H; Imamura T Oncol Rep; 2014 Oct; 32(4):1715-9. PubMed ID: 25050844 [TBL] [Abstract][Full Text] [Related]
14. Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis. Jian J; Pang Y; Yan HH; Min Y; Achyut BR; Hollander MC; Lin PC; Liang X; Yang L Oncotarget; 2017 Apr; 8(17):27725-27739. PubMed ID: 27223426 [TBL] [Abstract][Full Text] [Related]
15. Alternatively spliced tissue factor: a previously unknown piece in the puzzle of hemostasis. Szotowski B; Antoniak S; Rauch U Trends Cardiovasc Med; 2006 Jul; 16(5):177-82. PubMed ID: 16781952 [TBL] [Abstract][Full Text] [Related]
16. Tissue factor isoforms in cancer and coagulation: may the best isoform win. Kocatürk B; Versteeg HH Thromb Res; 2012 Apr; 129 Suppl 1():S69-75. PubMed ID: 22682138 [TBL] [Abstract][Full Text] [Related]